The UK is launching a major new NHS program to offer the meningitis B (MenB) vaccine to approximately one million young people, responding to a series of outbreaks that have caused deaths and heightened health concerns. The one-off vaccination campaign targets Year 13 students and individuals under 25 who are beginning university or residential further education this autumn. Health authorities emphasize that this initiative aims to protect those most vulnerable as they transition into environments where close contact facilitates disease spread.
Background of Outbreaks
The decision follows numerous MenB outbreaks in 2025, including a significant cluster in Kent, described as the largest and fastest-growing of its kind recorded in the UK. That outbreak resulted in two deaths and over 20 confirmed cases, with additional clusters reported in Reading and Dorset. Health experts identified an elevated risk of MenB infections among older teenagers and young adults, especially those moving into university halls and shared accommodations. Close social contact increases meningococcal disease transmission, making first-year university students particularly vulnerable. According to the UK Health Security Agency (UKHSA), the infection risk for these students is substantially higher compared to non-university peers.
Government Response
Health Secretary James Murray stated that recent outbreaks may indicate a shift in how the disease affects young people. He affirmed the government's immediate action to protect high-risk groups while reviewing long-term evidence. The program will offer two doses of the MenB vaccine, Bexsero (manufactured by GSK), administered at least 28 days apart for full protection. Vaccinations begin from July 20, with second doses scheduled for August. Students away during summer holidays can receive their second dose in September. Eligible individuals will be contacted via the NHS App, text, email, or letter, while others may book through participating pharmacies.
Eligibility Details
All Year 13 pupils in England and young people under 25 starting university or residential further education for the first time this autumn are eligible. The offer includes international students under 25 beginning studies in the UK. The first vaccinations commence July 20, with second doses in August. Students away during summer can still get their second dose in September. Eligible young people will be contacted through the NHS App, text messages, emails, or letters, while others may book appointments directly through participating pharmacies.
Meningitis B Risks
Meningitis B, caused by meningococcal group B bacteria, can lead to life-threatening conditions like meningitis (inflammation of brain and spinal cord membranes) and septicaemia (severe blood infection potentially leading to sepsis). Symptoms develop rapidly and include fever, severe headache, vomiting, drowsiness, light sensitivity, breathing difficulties, and a distinctive rash that does not fade under pressure. Even with treatment, the disease can cause permanent disability, neurological damage, or death. Although the UK has routinely vaccinated babies against MenB since 2015, most teenagers and young adults missed the childhood program, leaving a large population unprotected.
Impact of Kent Outbreak
The Kent cluster prompted intense scrutiny of the UK's MenB strategy. Health officials described it as unprecedented due to the speed of case emergence. Over 20 infections were linked to the outbreak, with two young deaths. One victim, 18-year-old Juliette Kenny, prompted her family to campaign for broader vaccination coverage for teenagers and young adults. The outbreak also raised questions about including MenB vaccination in the routine adolescent immunization program. Further clusters in Dorset and Reading reinforced concerns about increased risks for young adults.
Future Outlook
This rollout is a one-off emergency program, not a permanent expansion of NHS vaccination schedules. The Joint Committee on Vaccination and Immunisation (JCVI) is reviewing evidence and is expected to advise ministers on introducing a broader, long-term MenB vaccination program for teenagers. For now, health officials urge eligible students to get both doses before the academic year starts, warning that early protection could prevent further outbreaks when meningococcal disease typically peaks in autumn.
